When cells were cultured in control medium with anti-CD28 alone there were fewer cells secreting IFN-γ at W52 and 96 and fewer cells secreting IL-13 at W96 compared to untreated patients with RRMS. This evidence concerns the gene CD28 and relapsing-remitting multiple sclerosis.